These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 30323881)
1. Gd-EOB-DTPA DCE-MRI biomarkers in a rabbit model of liver fibrosis. Ji Y; Zhang C; Huang Z; Wang X; Yue L; Gao M; Hu H; Su Q; Han Y; Liu B; Yang D; Su Z; Zhang Z Am J Transl Res; 2018; 10(9):2949-2957. PubMed ID: 30323881 [TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced MRI with Gd-EOB-DTPA for the quantitative assessment of early-stage liver fibrosis induced by carbon tetrachloride in rabbits. Liu HF; Wang Q; Du YN; Zhu ZH; Li YF; Zou LQ; Xing W Magn Reson Imaging; 2020 Jul; 70():57-63. PubMed ID: 32325235 [TBL] [Abstract][Full Text] [Related]
3. Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Gd-EOB-DTPA for the Evaluation of Liver Fibrosis Induced by Carbon Tetrachloride in Rats. Zhang W; Kong X; Wang ZJ; Luo S; Huang W; Zhang LJ PLoS One; 2015; 10(6):e0129621. PubMed ID: 26076199 [TBL] [Abstract][Full Text] [Related]
4. Combining Pan S; Wang L; Xin J Life Sci; 2021 Mar; 269():119086. PubMed ID: 33476634 [TBL] [Abstract][Full Text] [Related]
5. Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA. Ryeom HK; Kim SH; Kim JY; Kim HJ; Lee JM; Chang YM; Kim YS; Kang DS Korean J Radiol; 2004; 5(4):231-9. PubMed ID: 15637473 [TBL] [Abstract][Full Text] [Related]
6. Comparison between T1 relaxation time of Gd-EOB-DTPA-enhanced MRI and liver stiffness measurement of ultrasound elastography in the evaluation of cirrhotic liver. Okada M; Murakami T; Yada N; Numata K; Onoda M; Hyodo T; Inoue T; Ishii K; Kudo M J Magn Reson Imaging; 2015 Feb; 41(2):329-38. PubMed ID: 24343840 [TBL] [Abstract][Full Text] [Related]
7. Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis. Keller S; Sedlacik J; Schuler T; Buchert R; Avanesov M; Zenouzi R; Lohse AW; Kooijman H; Fiehler J; Schramm C; Yamamura J Eur Radiol; 2019 Feb; 29(2):818-828. PubMed ID: 30014204 [TBL] [Abstract][Full Text] [Related]
8. Noninvasive Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B or C by Contrast-Enhanced Magnetic Resonance Imaging. Hako R; Kristian P; Jarčuška P; Haková I; Hockicková I; Schréter I; Janičko M Can J Gastroenterol Hepatol; 2019; 2019():3024630. PubMed ID: 31058108 [No Abstract] [Full Text] [Related]
9. Magnetic Resonance Diffusion Kurtosis Imaging for Evaluating Stage of Liver Fibrosis in a Rabbit Model. Li J; Wang D; Chen TW; Xie F; Li R; Zhang XM; Jing ZL; Yang JQ; Ou J; Cao JM Acad Radiol; 2019 Jun; 26(6):e90-e97. PubMed ID: 30072289 [TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance quantification of non-Gaussian water diffusion in hepatic fibrosis staging: a pilot study of diffusion kurtosis imaging to identify reversible hepatic fibrosis. Liu T; Hu J; Liu Y; Chen H; Guo D Ann Transl Med; 2021 Oct; 9(20):1569. PubMed ID: 34790775 [TBL] [Abstract][Full Text] [Related]
11. Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging. Li Z; Sun J; Chen L; Huang N; Hu P; Hu X; Han G; Zhou Y; Bai W; Niu T; Yang X J Magn Reson Imaging; 2016 Jul; 44(1):98-104. PubMed ID: 26707910 [TBL] [Abstract][Full Text] [Related]
12. [Gadolinium Ethoxybenzyl Diethylene-triamine-pentaacetic-acid-enhanced Magnetic Resonance Imaging Perfusion and Multiple Hepatobiliary-phase Imaging for Quantitative Assessment of Liver Fibrosis in Rat Models]. Xu J; Wang X; You Y; Xue HD; Wang Q; Wang ST; Jin ZY Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Dec; 40(6):809-816. PubMed ID: 30606393 [TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance elastography in a rabbit model of liver fibrosis: a 3-T longitudinal validation for clinical translation. Zou L; Jiang J; Zhong W; Wang C; Xing W; Zhang Z Am J Transl Res; 2016; 8(11):4922-4931. PubMed ID: 27904692 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of Rabbits Liver Fibrosis Using Gd-DTPA-BMA of Dynamic Contrast-Enhanced Magnetic Resonance Imaging. Cui Q; He F; Hu J; Li S; Guo D; Bie X; Liu W; Zhao Y Evid Based Complement Alternat Med; 2021; 2021():2791142. PubMed ID: 34567208 [TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted MRI-based Virtual Elastography for the Assessment of Liver Fibrosis. Kromrey ML; Le Bihan D; Ichikawa S; Motosugi U Radiology; 2020 Apr; 295(1):127-135. PubMed ID: 32043948 [TBL] [Abstract][Full Text] [Related]
16. Comparing and combining MRE, T1ρ, SWI, IVIM, and DCE-MRI for the staging of liver fibrosis in rabbits: Assessment of a predictive model based on multiparametric MRI. Zou L; Jiang J; Zhang H; Zhong W; Xiao M; Xin S; Wang Y; Xing W Magn Reson Med; 2022 May; 87(5):2424-2435. PubMed ID: 34931716 [TBL] [Abstract][Full Text] [Related]
17. Assessment of liver fibrosis in the early stages with perfusion CT. Wang L; Fan J; Ding X; Sun J; Zhang M Int J Clin Exp Med; 2015; 8(9):15276-82. PubMed ID: 26629014 [TBL] [Abstract][Full Text] [Related]
18. Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging. Pan S; Wang XQ; Guo QY World J Gastroenterol; 2018 May; 24(18):2024-2035. PubMed ID: 29760545 [TBL] [Abstract][Full Text] [Related]
19. Prediction of high-stage liver fibrosis using ADC value on diffusion-weighted imaging and quantitative enhancement ratio at the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI at 1.5 T. Harada TL; Saito K; Araki Y; Matsubayashi J; Nagao T; Sugimoto K; Tokuuye K Acta Radiol; 2018 May; 59(5):509-516. PubMed ID: 28853292 [TBL] [Abstract][Full Text] [Related]
20. [Value of susceptibility weighted imaging in hepatic fibrosis staging by using MR in a rabbit model]. Jiang J; Deng L; Ruan J; Cheng X; Zou L Zhonghua Yi Xue Za Zhi; 2016 May; 96(17):1371-6. PubMed ID: 27180758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]